Background. Childhood obesity is a significant health problem in the UK. To date, there is little known about the pattern of change in body mass index (BMI) following renal transplantation in UK paediatric patients. Our objectives in this study were to (i) describe trends in BMI seen in UK patients undergoing renal transplantation in the short and medium term and (ii) identify risk factors predisposing children to excessive weight gain following transplantation. Methods. A retrospective case note review was performed across 12 of 13 paediatric nephrology centres in the UK, with BMI measurements recorded pre-transplantation and for 4 years thereafter. BMI% was used to assess changes in adiposity over time. International Obesity Taskforce definitions of overweight and obesity were used to identify the prevalence of excess weight pre-and post-renal transplantation. Results. A total of 159 patients (113 boys) under the age of 18 with a functioning kidney transplant were included. Fifty-six patients (35.2%) were under the age of 5 at transplantation. Pretransplantation, 31.4% of patients were classified as overweight or obese, which increased to 52.8% by the end of follow-up. The majority of patients experienced rapid increases in BMI% over the initial four months post-transplantation, which were sustained for the remainder of the follow-up period. The major
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Background. Childhood obesity is a significant health problem in the UK. To date, there is little known about the pattern of change in body mass index (BMI) following renal transplantation in UK paediatric patients. Our objectives in this study were to (i) describe trends in BMI seen in UK patients undergoing renal transplantation in the short and medium term and (ii) identify risk factors predisposing children to excessive weight gain following transplantation. Methods. A retrospective case note review was performed across 12 of 13 paediatric nephrology centres in the UK, with BMI measurements recorded pre-transplantation and for 4 years thereafter. BMI% was used to assess changes in adiposity over time. International Obesity Taskforce definitions of overweight and obesity were used to identify the prevalence of excess weight pre-and post-renal transplantation. Results. A total of 159 patients (113 boys) under the age of 18 with a functioning kidney transplant were included. Fifty-six patients (35.2%) were under the age of 5 at transplantation. Pretransplantation, 31.4% of patients were classified as overweight or obese, which increased to 52.8% by the end of follow-up. The majority of patients experienced rapid increases in BMI% over the initial four months post-transplantation, which were sustained for the remainder of the follow-up period. The major risk factor for being overweight or obese at the end of follow-up was having excessive weight pre-transplantation. Four years following transplantation, the prevalence rate of overweight and obesity was much higher in our study cohort than the normal UK childhood population. Conclusions. The prevalence of patients classified as overweight or obese in the UK paediatric renal cohort is high pretransplantation and rises subsequently. Those at risk can be identified by an unhealthy BMI pre-transplantation and will require timely intervention with close monitoring in the subsequent post-transplantation period.
I N T RO D U C T I O N
Childhood obesity in the UK population is increasing in both its prevalence and severity [1] . Although children with established renal failure (ERF) often experience poor growth and nutrition, there are concerns that this cohort is also falling prey to the ongoing epidemic of unhealthy weight gain [2] . A recent report from the North American Paediatric Renal Transplant Cooperative Study (NAPRTCS) has reported adverse graft outcomes in obese children following transplantation [3] . Furthermore, incremental weight gain and obesity following transplantation in children is likely to add to their already increased cardiovascular risk [4] .
Weight gain following transplantation may be a natural consequence of improvement in renal function and appetite. In addition, excessive weight gain leading to obesity [5] may also be due to the use of corticosteroids or pulsed corticosteroid therapy for both maintenance immunosuppressive regimens or for the treatment of rejection episodes. Irrespective of the cause of excessive weight gain, a recent report by Foster et al. [6] , including the NAPRTCS cohort has observed that early weight gain following kidney transplantation persists for several years. Their observations highlight the importance of identifying patients at greatest risk of weight gain to allow introduction of preventative strategies in a timely fashion.
In order to monitor changes in adiposity in children, body mass index (BMI) is widely considered as a pragmatic proxy measure (BMI = weight in kilograms/height in metres 2 [2] ) and remains the most commonly used measure of adiposity in routine clinical practice in the UK [7] . During childhood, BMI is expressed relative to age and gender to reflect the physiological changes in body size and adiposity seen during growth in childhood. For longer term monitoring of changes in adiposity, it has been suggested that BMI expressed as a percentage difference from the median for age and height (BMI%) is a more useful measure [8] . Due to the positive skew in BMI distribution, larger children need to gain significantly more weight than their lighter peers to achieve the same change in BMI values alone. This is adjusted for by using BMI% and therefore allows standardization among study subjects.
To date, there is little European data describing the evolution of obesity in children following renal transplantation and investigating possible risk factors leading to its development. Our objectives in this study were to (i) describe observed trends in BMI over the early to medium term and (ii) identify risk factors predisposing children to excessive weight gain following kidney transplantation in the UK.
M AT E R I A L S A N D M E T H O D S
These data were collected as part of a nationwide study reviewing the management of blood pressure in children following renal transplantation on behalf of the British Association for Paediatric Nephrology (BAPN), the results of which were recently reported [9] .
Study population
The study population included all children and young adults for whom a BMI measurement was available at 'baseline' time point and at four years after transplantation, who were under the age of 18 years, had received a kidney-only transplant and were followed up in a paediatric nephrology centre within the UK.
Data collection method and handling of missing data Data for analysis were collected by retrospective case note review, which was undertaken by visiting 12 of 13 paediatric nephrology centres in the UK. Case note review was performed for every child who had a functioning renal transplant at the time of the centre visit. Data were collected from routine outpatient clinic visits, when the patient was stable, at pre-determined time points. Patients were excluded if they did not have a BMI recorded pre-transplantation and if follow up was for less than 4 years. Data collected at the following time-points was analysed: (i) at 'baseline' immediately pre-transplantation, (ii) at 1, 3, 6 and 12 months over the first year and (iii) at 6-monthly intervals until 4 years post-transplantation.
We collected the following information for all patients: gender, ethnicity, age at transplantation, allograft source (deceased or living donor), primary renal disease ('structural' such as renal cystic, dysplasia and obstructive uropathy or 'non-structural' such as glomerulonephritis) and whether transplant was pre-emptive (yes/no) dialysis modality immediately pre-transplantation. For each patient at each time point, we recorded the height in centimetres, weight in kilograms and BMI expressed as kilograms per metre squared. At the time of data collection, all included patients were receiving steroids as part of their immunosuppressive regimen. The reference range for height, weight and BMI in childhood varies with gender and age.
Standard deviation (Z) scores were calculated using UK 1990 reference data adjusted for age and sex [10] . To account for discrepancies in linear growth secondary to renal disease, BMI was expressed according to height-age, rather than chronological age. The International Obesity Taskforce (IOTF) definition proposed by Cole et al. [11] was used to define overweight and obesity. Using this definition, obesity is defined as a BMI z-score ≥2.25 in girls and ≥2.37 in boys. Overweight is defined as a BMI z-score ≥1.19 in girls and ≥1.30 in boys. A definition for underweight was based on percentile curves passing through adult definitions of underweight, which correlated with a BMI of 17 kg/m 2 at 18 years and is defined as a BMI z-score <−2.16 for boys and <−2.00 for girls [12] . BMI% is the percentage difference in BMI from median for age and height and was used to assess changes in adiposity, as recommended by Cole et al. [8] . BMI% was calculated as [100 × ln(BMI/median BMI for height-age and sex)] [8] . Renal function was expressed as estimated glomerular filtration rate (eGFR) using the recent Schwartz formula [13] .
We compared the prevalence of excess weight (overweight and obesity) in our cohort with published IOTF-based UK National averages for excess weight for the normal childhood population [14] .
Statistical analysis
Statistical analyses, including descriptive statistics, were conducted using χ 2 test, ANOVA and linear mixed effects modelling. Due to the unbalanced data that were collected, a linear mixed effects model was used to investigate factors (detailed below) that had an effect on changes in BMI% over time. Based on exploratory plots, it was decided to split the follow-up period into two time segments allowing the BMI% to change at different rates. This was due to the very rapid initial change after transplantation and the more stable subsequent follow up period. To find the most appropriate time point to split the follow-up period, models were compared where the time point was set to 3, 4, 6 and 12 months, and the model divided at 4 months was found to fit most closely to the
O R I G I N A L A R T I C L E
C h a n g e s i n b o d y m a s s i n d e x f o l l o w i n g r e n a l t r a n s p l a n t a t i o n data. The following factors were analysed for their effect on change in BMI% (dependent variable) including age at transplantation, gender, height z-score at transplantation, ethnicity, donor source, primary disease, whether a patient had received dialysis and dialysis modality pre-transplantation. All statistical analyses were performed using SAS 9.3.
R E S U LT S

Population characteristics
We reviewed case notes for 524 patients across 12 paediatric nephrology centres in the UK. They included children who had been transplanted between 1991 and 2003. In total, 484 (92.4%) patients had had their first transplant, 38 (7.2%) their second and 2 (0.4%) their third renal transplant. In this analysis, we included the 363 patients (69.3%) who had pre-transplant BMI data available. BMI data were available both at baseline and 4 years post-transplantation in 159 of 363 patients, who were subsequently analysed for changes in BMI over time. Table 1 summarizes clinical characteristics in this cohort pre-transplantation.
Prevalence across BMI groups at different time-points
Data is displayed at representative time points including at 'baseline' immediately pre-transplantation, 6, 24 and 48 months following transplantation in 159 subjects; there was no significant difference in findings at other time-points (data not shown). Pre-transplantation, 3.1% of patients were categorized as being underweight, with almost a third (31.4%) of all patients documented as being overweight or obese. By 4 years post-transplantation, the number of patients with a normal BMI had reduced from 104 (65.4%) to 75 patients (47.2%) while the proportion of those classified as overweight or obese had risen to 52.8%, with nearly half of these patients in the obese category. For additional details regarding prevalence rates of BMI for the 363 subjects by clinical category at these similar time points during the 4-year follow-up period, see Supplementary Material Appendix. Table 2 displays the change in BMI by category of the 159 children. Of those who were overweight pre-transplantation, just under half (47.2%) were subsequently classified as obese at the end of the follow-up period.
Comparison of excess weight (overweight and obesity) in this cohort with normal UK population Table 3 compares the proportion of excess weight in the study cohort with the published prevalence of overweight and obesity in the normal childhood population [14] . Pre-transplantation boys have a significantly higher prevalence rate of excess weight or obesity when compared with boys from normal UK childhood population. Four-years following transplantation both boys and girls had a significantly higher prevalence of excess weight or obesity when compared with the normal UK childhood population. Table 4 displays the clinical characteristics of all patients n = 159 when grouped by their BMI category at 4-years following transplantation. Obese patients were significantly more likely to be older when compared with younger transplant patients ( p = 0.01). There was evidence that patients who received dialysis prior to transplant were more likely to be overweight or obese at the time of transplantation than patients who received pre-emptive transplants ( p = 0.07, data not shown). The difference became more pronounced by the end of follow-up ( p = 0.02), although no differences were noted between dialysis modalities (haemodialysis versus peritoneal dialysis, p = 0.93). There was no significant difference between subjects in different BMI categories at 4-year post-transplantation for race, gender, height (at transplantation and at 4 years) and for GFR (at baseline and at 4 years). Donor source (living or deceased), transplant vintage (before or after 2000) and primary disease (structural or non-structural) were also analysed as variables of interest but there was no significant differences between the BMI categories (data not shown).
Changes in BMI following renal transplantation Pattern of change in BMI%. The overall mean BMI% (and 95% CIs) at 0, 6 and 48 months are 7.4 (5.0, 9.9), 16.5 (13.0, 19.9) and 20.2 (16.8, 23.5), respectively. Patients were observed to have a sharp increase in BMI% over the initial 4-month period following transplantation, with very little change in BMI% in the remaining follow-up period (Figure 1 ). This pattern was similar for patients in all baseline BMI categories, although the initial increase was slower for patients who had a higher BMI recorded pre-transplantation.
Determinants of change in BMI%. 
after the initial 4-month period immediately post-transplantation. Age at transplantation was the most significant factor but the effect it had was clinically small. For each additional year of age, a patient would be expected to be 0.17 BMI% points higher at the time of transplantation, and to increase by 1.2 BMI% points (0.306 × 4) in the first 4 months. Taking into account the number of risk factors that were tested, there was weak evidence that height and primary diagnosis of nonstructural renal disease had an impact on the rate of change in the first 4 months, and any difference is clinically small. Females had a lower initial BMI% but there was no difference between the sexes on the rate of change. Other risk factors that were included in the model but found to have no impact on the BMI% were ethnicity, donor source, transplant vintage and whether a patient had received dialysis before transplantation. Our data meant that for a typical boy with structural renal disease and of average height at the time of renal transplantation (height z-score of −1.97), the estimated BMI% at 0, 6 and 48 months following transplantation was 11.0, 18.0 and 19.7, respectively.
Changes in eGFR by BMI category following renal transplantation. When categorized by BMI z-scores based on height-age at each time point, a downward trend of eGFR was seen across all groups, irrespective of BMI classification. The differences seen between BMI categories did not reach statistical significance except at 6 months post-transplantation ( p = 0.005).
D I S C U S S I O N
Over the past two decades, obesity has become a significant health concern affecting children in the UK and across the developed world. Currently in the UK between 16 and 18% of boys and girls aged between 5 and 17 years are categorized as overweight or obese [14] . While national data suggest that the rate of increase in the prevalence of childhood obesity may be slowing, it remains at an undesirable level [1] . With an estimated annual cost to the National Health Service in the UK of Table 2 . Changes in BMI groups a using IOTF definitions [11, 12] , according to their baseline BMI on longitudinal follow-up 4 years after transplantation (n = 159) 
O R I G I N A L A R T I C L E
C h a n g e s i n b o d y m a s s i n d e x f o l l o w i n g r e n a l t r a n s p l a n t a t i o n [11, 12] .
£4.2 billion [15]
, there is increasing awareness of the need for timely intervention in the 'at risk' childhood population.
Pre-transplantation, 31.4% of our study population was documented as being overweight or obese. This figure is higher than reported in previous studies [2, 3] , which may be accounted for by the variation in study populations between countries as well as definitions used. Using IOTF definitions of excess weight, we have been able to make direct comparisons to published national data [14] and have shown that the prevalence of children who are overweight or obese pretransplantation is higher than the national average.
Post-transplantation, the overall trend seen was one of rapid changes in BMI% in the immediate 4-month period following transplantation, followed by stabilization. While this effectively eliminated the number of children who were classified as underweight, a greater proportion of children were classified as overweight or obese (52.8%) by the end of the study period. This suggests that aside from potential 'catch-up' growth seen in lighter children following an improvement in the biochemical milieu, there may be other important factors at play leading to a worrying degree of excess weight in this cohort. Children who were overweight or obese by 4 months following transplantation showed a maximum increase in BMI at this time point. While there was subsequent evidence of improvement in BMI, this did not return to pre-transplant values (Figure 1) . The same finding has been demonstrated by previous researchers [6] and seems to suggest that weight gained early on post-transplantation is sustained. It is interesting to note that between 12 and 36 months transient improvements were seen in both overweight and obese cohorts. We wondered whether this was related to a period of more frequent contact with health-care professionals providing support to reduce weight gain through dietary and lifestyle intervention. Other investigators have shown that obesity pretransplantation is increasing [3] so a focus on providing this kind of support will remain important. Two other studies with shorter follow-up periods have also reported changes in BMI [5, 16] and while our study confirms previous findings from North America, to our knowledge, this is the first study to describe changes in adiposity using analyses evaluating BMI% in children following renal transplantation in the UK.
We observed that older children as well as children requiring renal replacement therapy pre-transplantation were significantly more likely to be overweight or obese at the end of follow-up. Previous studies have also highlighted that increasing duration of dialysis is a further risk factor for increased prevalence of obesity post-transplantation [3] . These findings may be secondary to the aggressive use of supplemental nutrition in this cohort, but perhaps also to the greater use of peritoneal dialysis in paediatric patients leading to absorption of calories from the glucose content of dialysate [2, 16] .
In our cohort, one of the key risk factors identified for being overweight or obese following transplantation was being overweight or obese pre-transplantation. In the UK, the prevalence of obesity in the normal childhood population has been shown to increase with age, probably reflecting the accumulative effect of exposure to an obesogenic environment [17] . This may imply that following receiving a functioning renal transplant, patients already exposed to obesogenic influences are more likely to gain further weight.
The use of corticosteroids has been shown to cause growth retardation, fat deposition and appetite promotion [18] which may in this case have contributed to the marked increases in overweight and obesity seen. As all subjects included in our study were on corticosteroids, we are unable to comment on this any further. There is a growing body of evidence to suggest that early steroid withdrawal or even steroid-free immunosuppression post-transplantation may provide equivalent or even superior outcomes to standard steroid-containing protocols [19, 20] , which may in future help to eliminate this risk factor. Other authors, however, argue the impact of steroid avoidance on the growing rates of obesity seen is negligible [21] .
It is important to highlight that for the purpose of comparing with adult populations and for comparing obesity prevalence internationally, we have used IOTF criteria which use BMI cut-offs to define overweight and obesity that correlate with adult BMI values of 25 and 30 kg/m 2 respectively [11] . In adults, these values used to define overweight and obesity are based on cardiovascular health risk [22] . In children, this association is extrapolated rather than supported by any clear evidence. Using other definitions for overweight and obese BMI status did not alter our findings (see Supplementary Material Appendix for further details).
We have recently shown that patients who are obese prior to transplantation have a significant additional risk of progression to hypertension following transplantation when compared with their non-obese peers [9] . In a post-transplantation cohort, where cardiovascular disease remains one of the leading causes of death, additional strategies to reduce cardiovascular risk factors attendant on obesity such as hypertension, raised LDL and reduced HDL cholesterol are likely to improve long-term outcomes. Reduction of these risks is directly dependent on improving adiposity [23, 24] , and thus, we should encourage careful management of weight related issues both before and after renal transplantation. Reduced graft function over the short term as well as increased rates of graft loss and overall mortality have been reported in obese paediatric patients previously [3, 5] . While our study demonstrated significant reduction in GFR in subjects with excess weight at 6 months following transplantation, these differences in GFR did not remain significant on further follow-up.
The strengths of this study are that it includes data from 12 of 13 paediatric nephrology centres within the UK, thereby enabling us to gain a broad representation of the BMI trends. In order to assess weight gain, BMI% was used, which is the recommended method for monitoring changes in adiposity over time [8] . The data collection was also performed by investigators who carried out individual case note reviews. Limitations of this study include (i) missing data due to its retrospective design, which may introduce bias; (ii) while all of our patients received corticosteroids as part of their transplant management, like other authors we have been unable to accurately quantify the total cumulative dose received in each case, which may have some bearing on the increases in weight gain seen; (iii) we have not analysed the effect of dialysis duration as a factor affecting change in BMI%; (iv) although impossible to be precise it is unlikely that the change in BMI% observed here was significant as a result of 'regression to the mean'. This is because of the small within-individual variation in BMI data than the between-subject variation and (v) in addition, while obesogenic factors such as maternal BMI and socioeconomic status have previously been linked to increased weight gain and obesity, such parameters were not available to us to incorporate into our design.
In summary, our study has highlighted that the proportion of children with excess weight pre-transplant and all children several years following transplantation is higher than the normal childhood UK population; maximal increase in BMI is observed during the first 4 months following transplantation, with only slight improvement in those with excess weight even after 4 years following transplantation. Older children and those who are underweight at baseline are at greatest risk of increasing BMI% following transplantation. These issues need discussion pre-transplantation with timely strategies in the early post-transplantation period to identify those at risk and to implement 'excess weight' reduction strategies to help reduce the overall future cardiovascular morbidity and mortality observed in this population.
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